A research team led by Matthew Nystoriak, Ph.D., associate professor of biomedical research and translational medicine at ...

As 2024 draws to a close, HTX, a global digital asset trading platform, announces its Festive Season Campaign, offering a series of events for its users. Designed to enhance the trading experience ...

A cohort study found that patients with rheumatoid arthritis had an increased risk for heart failure, particularly with ...

Using computers to make a digital replica of the heart—a digital heart twin—can successfully identify problem areas deep in ...

The Predicting Risk of Cardiovascular Disease EVENTs (PREVENT) equations classify 15.0 million US adults as having an ...

It may open the door to new ways to treat and perhaps someday cure heart failure, the deadliest non-communicable disease on ...

Heart failure has historically been irreversible, but the outcome of a new study suggests that could someday change. At the University of Utah, scientists used a new gene therapy that was shown to ...

New gene therapy reverses heart failure in large animal model Date: December 10, 2024 Source: University of Utah Health Summary: In a single IV injection, a gene therapy targeting cBIN1 can ...

Congestive heart failure (CHF), often called heart failure, occurs when the heart is too weak to pump enough blood to the rest of the body. Damage to the heart muscle from a heart condition ...

A new gene therapy can reverse the effects of heart failure and restore heart function in a large animal model. The therapy increases the amount of blood the heart can pump and dramatically improves ...

HTX Ventures recently released the 2024 annual report that discusses the key developments in five sectors: the Bitcoin ecosystem, blockchain infrastructure, memecoins, artificial intelligence and ...

New Gene Therapy Reverses Heart Failure in Large Animal Model Dec. 10, 2024 — In a single IV injection, a gene therapy targeting cBIN1 can reverse the effects of heart failure and restore heart ...